Metodieva, G., Adoki, S., Lausen, B., & Metodiev, M. V. (2016). Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival. EBioMedicine.
Citação norma ChicagoMetodieva, Gergana, Samson Adoki, Berthold Lausen, and Metodi V. Metodiev. "Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival." EBioMedicine 2016.
Citação norma MLAMetodieva, Gergana, Samson Adoki, Berthold Lausen, and Metodi V. Metodiev. "Decreased Usage of Specific Scrib Exons Defines a More Malignant Phenotype of Breast Cancer With Worsened Survival." EBioMedicine 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.